Envafolimab clinical trials
Also written KN035.
How each study uses envafolimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the envafolimab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
71 studies that test it; most in 2022 (22)
| Year | Studies |
|---|---|
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 22 |
| 2023 | 16 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 13 · Other 58
3D Medicines (Sichuan) Co., Ltd. (8) · Sun Yat-sen University (6) · Tianjin Medical University Cancer Institute and Hospital (4) · Sir Run Run Shaw Hospital (3) · Fudan University (3) · Tracon Pharmaceuticals Inc. (2) · Ascletis Pharmaceuticals Co., Ltd. (2) · The First People's Hospital of Lianyungang (2)
Often tested with
Tested in the same studies.
Endostar protein (9) · Lenvatinib (7) · Surufatinib (2) · Futermestotug (1) · Tucidinostat (1) · Sacituzumab tirumotecan (1) · Axitinib (1) · CAPOX Regimen (1)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 18, 1 in phase 3
Studies that test envafolimab, phase 3 first.
- Nov 2026Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal AdenocarcinomaPhase 3 · Sir Run Run Shaw Hospital
- Dec 2026Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract CancerPhase 2 · Tongji Hospital
- Dec 2026Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial CancerPhase 2 · 3D Medicines (Sichuan) Co., Ltd.
- Dec 2026Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid TumorsPhase 1/2 · 3D Medicines (Sichuan) Co., Ltd.
- Dec 2026KN035 for dMMR/MSI-H Advanced Solid TumorsPhase 2 · 3D Medicines (Sichuan) Co., Ltd.
- Dec 2026ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRCPhase 2 · Beijing Hospital
- Dec 2026A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (A)Phase 2 · The Second Affiliated Hospital of Chongqing Medical University
- Dec 2026ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus InfectionPhase 4 · The Second Affiliated Hospital of Chongqing Medical University
- Dec 2026Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal CancerPhase 2 · Sun Yat-sen University
- Feb 2027Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.Phase 2 · Chongqing University Cancer Hospital
Studies
Open first, then newest update. How each study uses envafolimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 71
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (A)RecruitingPhase 2The Second Affiliated Hospital of Chongqing Medical UniversityNCT07852091Written as Sintilimab/Envafolimab
- Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal AdenocarcinomaRecruitingPhase 3Sir Run Run Shaw HospitalNCT05752136Written as Envafolimab
- SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLCNot yet recruitingPhase 2The First People's Hospital of LianyungangNCT07818304Written as Envafolimab
- A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver SpreadNot yet recruitingPhase 2Fudan UniversityNCT07256223Written as Envafolimab+Lenvatinib
- ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus InfectionRecruitingPhase 4The Second Affiliated Hospital of Chongqing Medical UniversityNCT07573943Written as Anti-PD-L1 antibody (ASC22)
- Study on the Combined Treatment of Hepatocellular Carcinoma With Envafolimab, Suvemcitug and HAIC ConversionNot yet recruitingNot applicableTianjin Medical University Cancer Institute and HospitalNCT07738055Written as Envafolimab: 400mg, subcutaneous injection Suvemcitug: 2mg/kg, intravenous injection HAIC: Oxaliplatin 85mg/m² + 5-FU 2400-3200mg/m², continuous infusion, every 3 weeks
- ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRCRecruitingPhase 2Beijing HospitalNCT06321081Written as irinotecan, cetuximab, envafolimab
- A Phase II Exploratory Study of Sacituzumab Tirumotecan Combined With Envafolimab for TROP2-Positive Advanced Biliary Tract Cancers Previously Treated With First-Line Immunotherapy Combined With Chemotherapy.Not yet recruitingPhase 2Tianjin Medical University Cancer Institute and HospitalNCT07729033Written as Sacituzumab tirumotecan combined with envafolimab
- Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard TreatmentRecruitingPhase 2Jian LiNCT07559864Written as Regorafenib + Envafolimab
- Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial CancerRecruitingPhase 23D Medicines (Sichuan) Co., Ltd.NCT05112991Written as Envafolimab+Lenvatinib
- Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid TumorsRecruitingPhase 1/23D Medicines (Sichuan) Co., Ltd.NCT05024214Written as Lenvatinib + Envafolimab
- ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid TumorsRecruitingPhase 23D Medicines (Sichuan) Co., Ltd.NCT04891198Written as Envafolimab
- Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.RecruitingPhase 2Chongqing University Cancer HospitalNCT06059261Written as Envafolimab and recombinant human endostatin combined with chemoradiotherapy
- Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal CancerRecruitingPhase 2Sun Yat-sen UniversityNCT05959356Written as Cetuximab + Envafolimab + mFOLFOXIRI
- Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell CarcinomaNot yet recruitingPhase 2Peking Union Medical College HospitalNCT07159191Written as Envafolimab Injection, Axitinib Tablets
- Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma PatientsNot yet recruitingPhase 2Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineNCT07142863Written as Envafolimab and neoadjuvant chemotherapy
- A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard TreatmentNot yet recruitingPhase 2Peking UniversityNCT06772233Written as regorafenib combined with envafolimab
- Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract CancerNot yet recruitingPhase 2Tongji HospitalNCT07003815Written as Envafolimab + Gemcitabine + Cisplatin + Simvastatin
- A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)Not yet recruitingPhase 2/3Sun Yat-sen UniversityNCT06959693Written as Envafolimab
- Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric CancerRecruitingPhase 2First Affiliated Hospital of Fujian Medical UniversityNCT06791083Written as Envafolimab
See all 71 studies that test envafolimab →
Given beside what is tested · 6 — envafolimab is usual care or a partner of the new treatment
- A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor PatientsRecruitingPhase 1Kangabio AUSTRALIA LTD PTYNCT07260305Written as Envafolimab
- Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and CarboplatinRecruitingPhase 2Shanghai Chest HospitalNCT06698965Written as Immunotherapy (Envafolimab)
- Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGSNot yet recruitingPhase 2Peking University Shenzhen HospitalNCT06692491Written as Envafolimab
- RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment FailureRecruitingPhase 1/2Tianjin Medical University Second HospitalNCT06663007Written as Envafolimab
- RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2Not yet recruitingPhase 2Jiangsu Cancer Institute & HospitalNCT05417230Written as Envafolimab
- A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid TumorsTerminatedPhase 2Jiangsu Simcere Pharmaceutical Co., Ltd.NCT05148195Written as Envofolimab
As the comparator · 1 — what is tested is compared with envafolimab
Codes
What other systems call envafolimab · ClinicalTrials.gg INT001692
- MeSH (NLM) C000718749envafolimabOne source NLM
- UNII (FDA) ES1M06M6QHENVAFOLIMABConfirmed FDA, NLM, Wikidata
- Wikidata Q123499516envafolimabConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C129714EnvafolimabOne source FDA
- DrugBank DB15769One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000718749 | envafolimab | One source NLM |
| UNII (FDA) | ES1M06M6QH | ENVAFOLIMAB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q123499516 | envafolimab | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C129714 | Envafolimab | One source FDA |
| DrugBank | DB15769 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.